TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES

淋巴细胞 DNA 断裂修复的拓扑机制

基本信息

  • 批准号:
    10305139
  • 负责人:
  • 金额:
    $ 47.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Summary Mammalian genomes are subject to a constant barrage of damage from metabolites, external agents, or physiologic processes, including transcription and replication. Developing lymphocytes also target double- strand breaks (DSBs) to antigen receptor loci during V(D)J recombination. To maintain genomic stability, DSBs must be repaired with high fidelity, minimizing oncogenic alterations such as chromosomal deletions and translocations. The DSB response extensively revises flanking chromatin via ATM-mediated phosphorylation of the histone variant H2Ax, producing γH2Ax, which spreads for 100s of kb around a DSB. In somatic cells, most of which are non-cycling, γH2Ax domains serve as chromatin-based platforms to facilitate repair by the non- homologous end joining (NHEJ) and, likely, as adherent surfaces to hold broken chromosome ends together. Indeed, ends are destabilized in cells lacking ATM or H2Ax, which have elevated levels of translocations. Thus, a deeper understanding of mechanisms that coordinate DSB repair and sequester ends from the rest of the genome remains an important goal. In this regard, links between repair, transcription, and epigenetic landscapes around DSBs are emerging. A feature that bridges many of these processes is the 3D conformation of chromatin, which determines the range of chromosomal contacts made by a persistent DSB. The applicant has shown that the topological “environment” of a DSB in non-cycling lymphocytes determines the spread and contours of γH2Ax domains, paralleling chromosome contacts of the break site. In addition, transcription of genes within γH2Ax domains was repressed, perhaps minimizing introduction of new breaks associated with RNA polymerase readthrough. A key finding from the prior funding period was that DSBs near the border of topologically-associated domains (TADs) produce highly asymmetric γH2Ax platforms on each chromosome end – one of which is very short – which may enhance disassociation of chromosome ends when the break persists. Indeed, genomic alterations, including those associated with cancer, are enriched near topological borders. Launching from these discoveries, the applicant now proposes to define the functional relationships between chromosome topology and DSB repair outcomes. Overarching hypotheses for three aims of the project are: (i) persistent DSBs adjacent to TAD borders will generate distinct profiles of repair products due to unstable association of chromosome ends, promoting extensive deletions and translocations, (ii) the mechanism of TAD formation, called loop extrusion, is required for generation of DDR platforms; impairment of this process will deleteriously affect repair outcomes, and (iii) transcription within a γH2Ax domain harboring a persistent DSB will enhance the probability of its deletional repair to an expressed gene with which it contacts. Together, the proposed project will fill fundamental knowledge gaps about how DSB responses integrate spatial, transcriptional, and chromatin-based mechanisms to sequester chromosome ends for efficient repair, minimizing their oncogenic potential in somatic cells.
摘要 哺乳动物基因组受到代谢物、外部因素或 生理过程,包括转录和复制。发育中的淋巴细胞也以双重目标为目标 在V(D)J重组过程中,链断裂(DSB)到抗原受体基因座。为了保持基因组的稳定性,DSB 必须高保真地修复,最大限度地减少致癌改变,如染色体缺失和 易位。DSB反应通过ATM介导的磷酸化广泛地修正侧翼染色质 组蛋白变异体H_2AX,产生γH_2AX,它围绕DSB扩散100s kb。在体细胞中,大多数 其中非循环的,γ的H2 AX结构域作为以染色质为基础的平台,促进非 同源末端连接(NHEJ),并可能作为粘附面将断裂的染色体末端结合在一起。 事实上,在缺乏ATM或H_2AX的细胞中,末端是不稳定的,这些细胞的易位水平升高。 因此,对协调DSB修复和隔离的机制的更深入理解结束于 基因组仍然是一个重要的目标。在这方面,修复、转录和表观遗传之间的联系 DSB周围的景观正在浮现。3D是连接这些过程中许多过程的一个功能 染色质的构象,它决定了持续的DSB形成的染色体接触的范围。 申请人已经证明,非循环淋巴细胞中DSB的拓扑环境决定了 γH_2AX结构域的扩展和轮廓,平行于断裂部位的染色体接触。此外, γH2 AX结构域中的基因转录受到抑制,可能会最大限度地减少新断裂的引入 与RNA聚合酶通读相关。上一个资金期的一个关键发现是,DSB接近 拓扑相关结构域(TAD)的边界在每个结构域上产生高度不对称的γH_2AX平台 染色体末端-其中一个很短-这可能会加强染色体末端的解离,当 这种裂痕依然存在。事实上,基因组的改变,包括那些与癌症相关的改变,几乎是浓缩的 拓扑边界。从这些发现出发,申请人现在建议定义功能 染色体拓扑结构与DSB修复结果之间的关系。三个最重要的假设 该项目的目标是:(1)与TAD边界相邻的永久性DSB将产生不同的修复轮廓 由于染色体末端的不稳定关联,促进了广泛的缺失和易位, (2)生成DDR平台需要TAD形成机制,称为环状挤压; 这一过程的损伤将有害地影响修复结果,以及(Iii)γH2AX内的转录 含有持久性DSB的结构域将增加其对表达基因的缺失修复的可能性 它与之接触的。总之,拟议的项目将填补有关DSB如何实现的基本知识空白 响应整合了空间、转录和染色质的机制,以隔离染色体末端 为了有效的修复,将它们在体细胞中的致癌潜力降至最低。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eugene M Oltz其他文献

Increased COVID-19 Mortality and Deficient SARS-CoV-2 Immune Response Are Not Associated with Higher Levels of Endemic Coronavirus Antibodies
COVID-19 死亡率增加和明确的 SARS-CoV-2 免疫反应与地方性冠状病毒抗体水平升高无关
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bindu Adhikari;Eugene M Oltz;J. Bednash;J. C. Horowitz;J. Amimo;Sergei A. Raev;Soledad Fernández;M. Anghelina;Shan;Mark P. Rubinstein;Daniel M. Jones;Linda J. Saif;A. Vlasova
  • 通讯作者:
    A. Vlasova
Essential function for SWI-SNF chromatin-remodeling complexes in the promoter-directed assembly of Tcrb genes
SWI-SNF 染色质重塑复合物在 Tcrb 基因启动子指导组装中的基本功能
  • DOI:
    10.1038/ni1481
  • 发表时间:
    2007-06-24
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Oleg Osipovich;Robin Milley Cobb;Kenneth J Oestreich;Steven Pierce;Pierre Ferrier;Eugene M Oltz
  • 通讯作者:
    Eugene M Oltz

Eugene M Oltz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eugene M Oltz', 18)}}的其他基金

Project 1: COVID-19 prevalence, transmission, and protection in extended first responder cohorts
项目 1:扩大急救人员群体中的 COVID-19 流行率、传播和保护
  • 批准号:
    10688392
  • 财政年份:
    2020
  • 资助金额:
    $ 47.21万
  • 项目类别:
Core B: Testing and Biorepository
核心 B:测试和生物样本库
  • 批准号:
    10688388
  • 财政年份:
    2020
  • 资助金额:
    $ 47.21万
  • 项目类别:
Core B: Testing and Biorepository
核心 B:测试和生物样本库
  • 批准号:
    10222408
  • 财政年份:
    2020
  • 资助金额:
    $ 47.21万
  • 项目类别:
Project 1: COVID-19 prevalence, transmission, and protection in extended first responder cohorts
项目 1:扩大急救人员群体中的 COVID-19 流行率、传播和保护
  • 批准号:
    10222410
  • 财政年份:
    2020
  • 资助金额:
    $ 47.21万
  • 项目类别:
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA
序列特异性染色质修饰剂;
  • 批准号:
    8885259
  • 财政年份:
    2015
  • 资助金额:
    $ 47.21万
  • 项目类别:
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES
淋巴细胞 DNA 断裂修复的拓扑机制
  • 批准号:
    10663321
  • 财政年份:
    2015
  • 资助金额:
    $ 47.21万
  • 项目类别:
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES
淋巴细胞 DNA 断裂修复的拓扑机制
  • 批准号:
    10415222
  • 财政年份:
    2015
  • 资助金额:
    $ 47.21万
  • 项目类别:
Topological Mechanisms of DNA Break Repair in Lymphocytes
淋巴细胞DNA断裂修复的拓扑机制
  • 批准号:
    9899620
  • 财政年份:
    2015
  • 资助金额:
    $ 47.21万
  • 项目类别:
LOCALIZED REVISION OF EPIGENETIC LANDSCAPES INDUCED BY DNA DOUBLE-STRAND BREAKS
DNA 双链断裂引起的表观遗传景观的局部修正
  • 批准号:
    8197622
  • 财政年份:
    2010
  • 资助金额:
    $ 47.21万
  • 项目类别:
TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS
针对非霍奇金淋巴瘤的表观基因组特征进行新疗法
  • 批准号:
    8699694
  • 财政年份:
    2010
  • 资助金额:
    $ 47.21万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.21万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了